🔎 Trials Near Me

Beranda › Glioblastoma › Florida › Miami

Uji klinis Glioblastoma di Miami, FL

14 studi untuk Glioblastoma mencari peserta di lokasi sekitar Miami (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Menerima pesertaFase 2
  • Baptist Health Herbert Wertheim Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06991101

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Menerima pesertaFase 1/2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05432804

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Menerima pesertaFase 2/3
  • Sylvester Comprehensive Cancer Center*, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT03970447

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Menerima pesertaFase 3
  • Miami Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05902169

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Menerima pesertaFase 2
  • Miami Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Menerima pesertaFase 1
  • University of Miami (Data collection only), Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06934889

Targeted Pediatric High-Grade Glioma Therapy

Menerima pesertaStudi observasional
  • University of Miami, Miami
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Menerima pesertaFase 1
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06860594

Study of Olutasidenib and Temozolomide in HGG

Menerima pesertaFase 2
  • University of Miami Hospital and Clinics, Miami
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Menerima pesertaFase 3
  • University of Miami Health, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05303519

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

Menerima peserta
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT05284643

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

Menerima pesertaStudi observasional
  • Miami Cancer Institute at Baptist Health, Inc., Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT05756985

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Menerima pesertaFase 1/2Sukarelawan sehat diterima
  • Jackson Memorial Hospital, Miami
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 8 Des 2025 · NCT05956821

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Miami
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Glioblastoma di kota lain

Studi lain di Miami

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.